Tailored treatments to fight superbugs
New research from Monash University and the University of Queensland could change the way critically ill patients across the world are treated.
Jun 13, 2016
0
0
New research from Monash University and the University of Queensland could change the way critically ill patients across the world are treated.
Jun 13, 2016
0
0
Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients ...
May 13, 2016
0
1
The World Health Organization approved a new treatment for multi-drug resistant tuberculosis (MDR-TB) on Thursday, a crucial step towards replacing an old, costly therapy that is brutal on patients and only 50-percent effective.
May 12, 2016
0
1
While use of the standard therapy leading to the best outcome against locally advanced rectal cancer has increased over the past decade, only half of patients currently receive it, according to a new study. The authors of ...
Apr 13, 2016
0
3
Patients with Obsessive-Compulsive Disorder (OCD) can improve their symptoms significantly by adding exposure and response prevention therapy to their treatment regimen when common drug treatment options have failed, according ...
Nov 11, 2015
0
49
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.
Oct 22, 2015
0
14
Research with human tissue and cells suggests that genetic variations, in addition to failure to comply with treatment regimens, may account for some failures of an anti-HIV drug to treat and prevent HIV infection.
Jul 9, 2015
0
11
Researchers from the University of Leicester and Leicester's Hospitals have discovered that many people suffering from type 2 diabetes also suffer from low blood sugar levels that can pose a significant risk to their health.
Jun 18, 2015
0
26
Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now ...
Mar 18, 2015
0
53
By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center (NCCC), led by Chao Cheng, PhD, have identified a gene signature ...
Jan 7, 2015
0
11